Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bavarian Nordic
Pharma
Bavarian Nordic's longtime CEO Paul Chaplin to depart
Chaplin, who became CEO in 2014, said in a statement Monday that he’s stepping down because his family wants to return to Australia.
Fraiser Kansteiner
Mar 2, 2026 10:23am
Bavarian Nordic's board chair departs after acquisition fumble
Nov 13, 2025 4:41pm
Bavarian Nordic shares plunge as proposed takeover falls through
Nov 6, 2025 1:38pm
After lifting pause, FDA suspends use of Valneva's Ixchiq
Aug 25, 2025 11:29am
As Bavarian Nordic reports sales boost, CEO pushes for takeover
Aug 22, 2025 11:30am
FDA lifts pause of Valneva's chikungunya vaccine in older adults
Aug 7, 2025 10:42am
